Aging · 2018 · 28 citations · 52 references
Life SciencesNeurosciencePharmacologyDementiaNeurodegenerationNeuropharmacologyAlzheimer DiseaseNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationNeuroprotectionAlzheimer Disease NeuroprotectionNeuroinflammation In Alzheimer DiseaseNeuroinflammatory CytokinesOxidative Stress In NeurodegenerationPharmacological Treatment Of DementiaPlant Extract AntioxidantsProinflammatory MediatorsTau Hyperphosphorylation
(TG), a naturally occurring plant known for its strong antioxidative, anti-inflammatory and anti-amyloidogenic properties, was evaluated on homocysteine (Hcy) induced AD-like pathology and cognitive impairments in rats. We found that TG attenuated Hcy-induced oxidative stress and memory deficits. TG also improved neurodegeneration and neuroinflammation by upregulating synaptic proteins such as PSD95 and synapsin 1 and downregulating inflammatory markers including CD68 and GFAP with concomitant decrease in proinflammatory mediators interlukin-1β (IL1β) and tumor necrosis factor α (TNFα). TG attenuated tau hyperphosphorylation at multiple AD-related sites through decreasing some kinases and increasing phosphatase activities. Moreover, TG rescued amyloid-β (Aβ) pathology through downregulating BACE1. Our data for the first time provide evidence that TG attenuates Hcy-induced AD-like pathological changes and cognitive impairments, making TG a promising candidate for the treatment of AD-associated pathological changes.
52
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
Robert Clarke, A. David Smith, Kim A. Jobst et al. · Archives of Neurology · 1998 · 1.4K citations
Medicine, Geriatric Medicine, Aging +16